Cardiopatia coronarica e depressione: prevalenza, prognosi, fisiopatologia e trattamento

  • K. Maier
  • D. Chatkoff
  • M. M. Burg


La comorbilità di depressione e cardiopatia coronarica (coronary heart disease, CHD) è stata dimostrata da un vasto numero di pubblicazioni edite nel corso degli ultimi due decenni. In questa sede riassumiamo lo stato della letteratura, ponendo particolare attenzione alla diffusione della CHD e della depressione, alla relazione tra la depressione e lo sviluppo e la prognosi della CHD ed ai meccanismi fisiopatologici attraverso i quali questi due fenomeni clinici potrebbero essere legati.Vengono anche discusse le questioni chiave rilevanti per la valutazione e il trattamento sia nella pratica clinica sia nella ricerca.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Smith TW, Leon AS (1992) Coronary heart disease: a behavioral perspective. Research Press, Champaign, ILLGoogle Scholar
  2. 2.
    Katzel LI, Waldstein SR (2001) Classification of cardiovascular disease. In: Waldstein SR, Elias MF (eds) Neuropsychology of cardiovascular disease. Erlbaum, Mahwah, NJ, pp 3–14Google Scholar
  3. 3.
    World Health Organization (2000) Annual incidence for selected causes: by sex, age and WHO subregion: 2000 version 2. Retrieved December 5, 2003, from the World Health Organization Statistical Information SystemGoogle Scholar
  4. 4.
    World Health Organization (2000) Point prevalence for selected causes: by sex, age and WHO subregion: 2000 version 2. Retrieved December 5, 2003, from the World Health Organization Statistical Information SystemGoogle Scholar
  5. 5.
    American Heart Association (2003) Heart disease and stroke statistics — 2004 update. American Heart Association, Dallas, TXGoogle Scholar
  6. 6.
    American Heart Association (2004) Heart attack and angina statistics. Available from the American Heart Association Web site, http://www. Americanheart. OrgGoogle Scholar
  7. 7.
    Ross R (1991) Atherosclerosis-an inflammatory disease. N Eng J Med 340:115–126CrossRefGoogle Scholar
  8. 8.
    Entman ML, Ballantyne CM (1993) Inflammation in acute coronary syndromes. Circulation 88:800–803PubMedGoogle Scholar
  9. 9.
    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (4th ed). Author, Washington, DCGoogle Scholar
  10. 10.
    American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (4th ed, text revision). Author, Washington, DCCrossRefGoogle Scholar
  11. 11.
    Kessler RC, Berglund P, Demler O et al (2003) The epidemiology of major depressive disorder. JAMA 289:3095–3105PubMedCrossRefGoogle Scholar
  12. 12.
    Musselman DL, Evans DL, Nemeroff CB (1998) The relationship of depression to cardiovascular disease. Arch Gen Psych 55:580–592CrossRefGoogle Scholar
  13. 13.
    Lane D, Carroll D, Ring C et al (2002) The prevalence and persistence of depression and anxiety following myocardial infarction. Brit J Health Psychol 7:11–21CrossRefGoogle Scholar
  14. 14.
    Beck AT, Rush AJ, Shaw BF, Emery G (1979) Cognitive therapy of depression. Guilford Press, New YorkGoogle Scholar
  15. 15.
    Schleifer SJ, Macari-Hinson MM, Coyle DA et al (1989) The nature and course of depression following myocardial infarction. Arch Intern Med 149:1785–1789PubMedCrossRefGoogle Scholar
  16. 16.
    Langeluddecke P, Fulcher G, Baird D et al (1989) A prospective evaluation of the psychosocial effects of coronary artery bypass surgery. J Psychosom Res 33:37–45PubMedCrossRefGoogle Scholar
  17. 17.
    McKhann GM, Borowicz LM, Goldsborough MA et al (1997) Depression and cognitive decline after coronary artery bypass grafting. Lancet 349:1282–1284PubMedCrossRefGoogle Scholar
  18. 18.
    Ziegelstein RC (2001) Depression in patients recovering from a myocardial infarction. JAMA 286:1621–1627PubMedCrossRefGoogle Scholar
  19. 19.
    Denollet J (1993) Emotional distress and fatigue in coronary heart disease: the Global Mood Scale (GMS). Psychol Med 23:111–121PubMedCrossRefGoogle Scholar
  20. 20.
    Lesperance F, Frasure-Smith N, Talajic M (1996) Major depression before and after myocardial infarction: its nature and consequences. Psychosom Med 58:99–110PubMedGoogle Scholar
  21. 21.
    Mayou RA, Gill D, Thompson DR et al (2000) Depression and anxiety as predictors of outcome after myocardial infarction. Psychosom Med 62:212–219PubMedGoogle Scholar
  22. 22.
    Rugulies R (2002) Depression as a predictor for a coronary heart disease: a review and meta-analysis. Am J Prev Med 23:51–61PubMedCrossRefGoogle Scholar
  23. 23.
    Scherrer JF, Xian H, Bucholz KK et al (2003) A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosom Med 65:548–557PubMedCrossRefGoogle Scholar
  24. 24.
    Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML (2000) Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med 160:1261–1268PubMedCrossRefGoogle Scholar
  25. 25.
    Cohen HW, Madhavan S, Alderman MH (2001) History of treatment for depression: risk factor for myocardial infarction in hypertensive patients. Psychosom Med 63:203–209PubMedGoogle Scholar
  26. 26.
    Frasure-Smith N, Lesperance F, Talajic M (1993) Depression following myocardial infarction: impact on 6-month survival. JAMA 270:1819–1825PubMedCrossRefGoogle Scholar
  27. 27.
    Frasure-Smith N, Lesperance F (1995). Depression and 18-month prognosis after myocardial infarction. Circulation 91:999–1005PubMedGoogle Scholar
  28. 28.
    Frasure-Smith N, Lesperance F (2003) Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry 60:627–636PubMedCrossRefGoogle Scholar
  29. 29.
    Bush DE, Ziegelstein RC, Tayback M et al (2001) Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 88:337–341PubMedCrossRefGoogle Scholar
  30. 30.
    Burg MM, Benedetto MC, Rosenberg R, Soufer R (2003) Presurgical depression predicts medical morbidity 6 months after coronary artery bypass graft surgery. Psychosom Med 65:111–118PubMedCrossRefGoogle Scholar
  31. 31.
    Burg MM, Benedetto MC, Soufer R (2003) Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom Med 65:508–510PubMedCrossRefGoogle Scholar
  32. 32.
    Connerney I, Shapiro PA, McLaughlin JS et al (2000) In-hospital depression after CABG surgery predicts 12-month outcome. Lancet 358:1766–1771CrossRefGoogle Scholar
  33. 33.
    Blumenthal JA, Lett HS, Babyak MA et al (2003) Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet 362:604–609PubMedCrossRefGoogle Scholar
  34. 34.
    Maes M, Bosmans E, De Jongh et al (1997) Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine 9:853–858PubMedCrossRefGoogle Scholar
  35. 35.
    Kiecolt-Glaser JK, Glaser R (2002) Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 53:873–876PubMedCrossRefGoogle Scholar
  36. 36.
    Dantzer R, Wollman EE, Vitkovic L, Yirmiya R (1999) Cytokines, stress, and depression. Conclusions and perspectives. Adv Exp Med Biol 461:317–329PubMedCrossRefGoogle Scholar
  37. 37.
    Severus WE, Littman AB, Stoll AL (2001) Omega-3 fatty acids, homocysteine, and the increased risk of cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry 9:280–293PubMedCrossRefGoogle Scholar
  38. 38.
    Miller GE, Stetler CA, Carney RM (2002) Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol 90:1279–1283PubMedCrossRefGoogle Scholar
  39. 39.
    Miller GE, Freedland KE, Carney RM et al (2003) Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 17:276–285PubMedCrossRefGoogle Scholar
  40. 40.
    Goodman E, Whitaker RC (2002) A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 109:497–504CrossRefGoogle Scholar
  41. 41.
    Krantz DS, Manuck SB (1984) Acute psychophysiologic reactivity and risk of cardiovascular disease: a review and methodological critique. Psychol Bull 96:435–464PubMedCrossRefGoogle Scholar
  42. 42.
    Schins A, Honig A, Crijns H et al (2003) Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link? Psychosom Med 65:729–737PubMedCrossRefGoogle Scholar
  43. 43.
    Wirtz PH, von Kanel R, Schnorpfeil P et al (2003) Reduced glucocorticoid sensitivity of monocyte interleukin-6 production in male industrial employees who are vitally exhausted. Psychosom Med 65:672–678PubMedCrossRefGoogle Scholar
  44. 44.
    Appels A, Kop WJ, Schouten E (2000) The nature of the depressive symptomatology preceding myocardial infarction. Behav Med 26:86–89PubMedCrossRefGoogle Scholar
  45. 45.
    Stein PK, Carney RM, Freedland KE et al (2000) Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J Psychosom Res 48:493–500PubMedCrossRefGoogle Scholar
  46. 46.
    Schwarz AM, Schachinger H, Adler RH, Goetz SM (2003) Hopelessness is associated with decreased heart rate variablility during championship chess games. Psychosom Med 65:658–661PubMedCrossRefGoogle Scholar
  47. 47.
    Hughes JW, Stoney CM (2000) Depressed mood is related to high-frequency heart rate variability during stressors. Psychosom Med 62:796–803PubMedGoogle Scholar
  48. 48.
    Ariyo AA, Haan M, Tangen CM et al (2000) Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 102:1773–1779PubMedGoogle Scholar
  49. 49.
    Glassman AH, Helzer JE, Covey LS et al (1990) Smoking, smoking cessation, and major depression. JAMA 264:1546–1549PubMedCrossRefGoogle Scholar
  50. 50.
    Goodwin RD (2003) Association between physical activity and mental disorders among adults in the United States. Prevent Med 36:698–703CrossRefGoogle Scholar
  51. 51.
    Rosal MC, Ockene JK, Ma Y et al (2001) Behavioral risk factors among members of a health maintenance organization. Prevent Med 33:586–594CrossRefGoogle Scholar
  52. 52.
    Ziegelstein RC, Fauerbach JA, Stevens SS et al (2000) Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 160:1818–1823PubMedCrossRefGoogle Scholar
  53. 53.
    Carney RM, Freedland KE, Miller GE, Jaffe AS (2002) Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 53:897–902PubMedCrossRefGoogle Scholar
  54. 54.
    Hippisley-Cox J, Fielding K, Pringle M (1998) Depression as a risk factor for ischemic heart disease in men: population based case-control study. Brit Med J 316:1714–1719PubMedGoogle Scholar
  55. 55.
    Anda R, Williamson D, Jones D et al (1993) Depressed affect, hopelessness, and risk of ischemic heart disease in a cohort of US adults. Epidemiology 4:285–294PubMedCrossRefGoogle Scholar
  56. 56.
    Freedland KE, Skala JA, Carney RM et al (2002) The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med 64:897–905PubMedCrossRefGoogle Scholar
  57. 57.
    ENRICHD Investigators (2001) Enhancing Recovery in Coronary Heart Disease (ENRICHD) study intervention: rationale and design. Psychosom Med 63:747–755Google Scholar
  58. 58.
    ENRICHD Investigators (2003) Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289:3106–3116CrossRefGoogle Scholar
  59. 59.
    Carney RM, Rich MW, Freedland KE et al (1988) Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 50:627–633PubMedGoogle Scholar
  60. 60.
    Radloff LS (1977) The CES-D Scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1:385–401Google Scholar
  61. 61.
    Linden W, Stossel C, Maurice J (1996) Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 156:745–752PubMedCrossRefGoogle Scholar
  62. 62.
    Frasure-Smith N, Lesperance F, Prince RH et al (1997) Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 350:473–479PubMedCrossRefGoogle Scholar
  63. 63.
    Cossette S, Frasure-Smith N, Lesperance F (1999) Impact of improving psychological distress in post-MI patients. Psychosom Med 61:93Google Scholar
  64. 64.
    Beck JS (1995) Cognitive therapy: basics and beyond. Guilford Press, New YorkGoogle Scholar
  65. 65.
    Glassman AH, Roose SP, Bigger JT Jr (1993) The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 269:2673–2675PubMedCrossRefGoogle Scholar
  66. 66.
    Cohen HW, Gibson G, Aldermann MH (2000) Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Me 108:2–8CrossRefGoogle Scholar
  67. 67.
    Glassman AH, O’Connor CM, Califf RM et al (2002) Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288:701–709PubMedCrossRefGoogle Scholar
  68. 68.
    Frasure-Smith N, Lesperance F (2003) Depression: a cardiac risk factor in search of a treatment. JAMA 289:3171–3173PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • K. Maier
    • 1
  • D. Chatkoff
    • 2
  • M. M. Burg
    • 3
    • 4
  1. 1.Psychology DepartmentSalisbury UniversitySalisburyUSA
  2. 2.Department of Behavioral Sciences PsychologyUniversity of Michigan-DearbornDearbornUSA
  3. 3.Behavioral Cardiovascular Health and Hypertension Program Department of MedicineColumbia University School of MedicineNew YorkUSA
  4. 4.Section of Cardiovascular MedicineYale University School of MedicineNew HavenUSA

Personalised recommendations